• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与前列腺癌风险:基于国民健康保险的研究。

Diabetes and risk of prostate cancer: a study using the National Health Insurance.

机构信息

National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.

DOI:10.2337/dc10-1640
PMID:21273499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3041193/
Abstract

OBJECTIVE

The link between diabetes and prostate cancer is rarely studied in Asians.

RESEARCH DESIGN AND METHODS

The trend of age-standardized prostate cancer incidence in 1995-2006 in the Taiwanese general population was calculated. A random sample of 1,000,000 subjects covered by the National Health Insurance in 2005 was recruited. A total of 494,630 men for all ages and 204,741 men ≥ 40 years old and without prostate cancer at the beginning of 2003 were followed to the end of 2005. Cumulative incidence and risk ratio between diabetic and nondiabetic men were calculated. Logistic regression estimated the adjusted odds ratios for risk factors.

RESULTS

The trend of prostate cancer incidence increased significantly (P < 0.0001). The cumulative incidence markedly increased with age in either the diabetic or nondiabetic men. The respective risk ratio (95% CI) for all ages and age 40-64, 65-74, and ≥ 75 years was 5.83 (5.10-6.66), 2.09 (1.60-2.74), 1.35 (1.07-1.71), and 1.39 (1.12-1.71). In logistic regression for all ages or for age ≥ 40 years, age, diabetes, nephropathy, ischemic heart disease, dyslipidemia, living region, and occupation were significantly associated with increased risk, but medications including insulin and oral antidiabetic agents were not.

CONCLUSIONS

Prostate cancer incidence is increasing in Taiwan. A positive link between diabetes and prostate cancer is observed, which is more remarkable in the youngest age of 40-64 years. The association between prostate cancer and comorbidities commonly seen in diabetic patients suggests a more complicated scenario in the link between prostate cancer and diabetes at different disease stages.

摘要

目的

糖尿病与前列腺癌之间的关联在亚洲人群中鲜有研究。

研究设计和方法

计算了 1995-2006 年台湾普通人群中年龄标准化前列腺癌发病率的趋势。2005 年,以全民健康保险涵盖的 100 万随机抽样人群为研究对象,招募了所有年龄的 494630 名男性和 204741 名年龄≥40 岁且在 2003 年初无前列腺癌的男性,并随访至 2005 年底。计算了糖尿病和非糖尿病男性的累积发病率和风险比。采用 logistic 回归估计了危险因素的调整比值比。

结果

前列腺癌发病率呈显著上升趋势(P<0.0001)。糖尿病或非糖尿病男性的累积发病率均随年龄显著增加。所有年龄组及年龄 40-64、65-74、≥75 岁组的风险比(95%CI)分别为 5.83(5.10-6.66)、2.09(1.60-2.74)、1.35(1.07-1.71)和 1.39(1.12-1.71)。在所有年龄组或年龄≥40 岁组的 logistic 回归中,年龄、糖尿病、肾病、缺血性心脏病、血脂异常、居住地区和职业与风险增加显著相关,但包括胰岛素和口服降糖药在内的药物治疗无此关联。

结论

台湾的前列腺癌发病率正在上升。观察到糖尿病与前列腺癌之间存在正相关,在 40-64 岁的最年轻年龄组更为显著。前列腺癌与糖尿病患者常见合并症之间的关联表明,在不同疾病阶段,前列腺癌与糖尿病之间的关联更为复杂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36d/3041193/2e13b7998371/616fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36d/3041193/cd08e0df1a88/616fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36d/3041193/2e13b7998371/616fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36d/3041193/cd08e0df1a88/616fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c36d/3041193/2e13b7998371/616fig2.jpg

相似文献

1
Diabetes and risk of prostate cancer: a study using the National Health Insurance.糖尿病与前列腺癌风险:基于国民健康保险的研究。
Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.
2
Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.2型糖尿病与肾癌风险:一项基于国民健康保险的回顾性队列分析
PLoS One. 2015 Nov 11;10(11):e0142480. doi: 10.1371/journal.pone.0142480. eCollection 2015.
3
Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.糖尿病而非胰岛素会增加患肺癌风险:一项基于台湾人群的研究。
PLoS One. 2014 Jul 3;9(7):e101553. doi: 10.1371/journal.pone.0101553. eCollection 2014.
4
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan.糖尿病与非霍奇金淋巴瘤:2005 年基于台湾全民健康保险数据库的流行率与年发病率分析。
Ann Oncol. 2012 Jan;23(1):153-158. doi: 10.1093/annonc/mdr334. Epub 2011 Jul 15.
5
Human insulin does not increase prostate cancer risk in Taiwanese.人胰岛素不会增加台湾男性罹患前列腺癌的风险。
Clin Genitourin Cancer. 2014 Feb;12(1):e7-12. doi: 10.1016/j.clgc.2013.08.004. Epub 2013 Oct 11.
6
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.糖尿病与膀胱癌风险:一项基于台湾全民健康保险数据库的研究。
Diabetologia. 2011 Aug;54(8):2009-15. doi: 10.1007/s00125-011-2171-z. Epub 2011 May 5.
7
Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men.台湾男性前列腺癌死亡率:一般人群中年龄标准化趋势上升,糖尿病男性风险增加。
Ann Med. 2011 Mar;43(2):142-50. doi: 10.3109/07853890.2010.530683. Epub 2011 Feb 1.
8
The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients.在台湾地区患者中,糖尿病与肝癌、结肠癌、肺癌和前列腺癌的相关性独立于高血压、高血脂和痛风。
Metabolism. 2012 Feb;61(2):242-9. doi: 10.1016/j.metabol.2011.06.020. Epub 2011 Aug 4.
9
Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.二甲双胍可显著降低台湾2型糖尿病男性患前列腺癌的风险。
Eur J Cancer. 2014 Nov;50(16):2831-7. doi: 10.1016/j.ejca.2014.08.007. Epub 2014 Sep 5.
10
Oral cancer in Taiwan: is diabetes a risk factor?台湾口腔癌:糖尿病是危险因素吗?
Clin Oral Investig. 2013 Jun;17(5):1357-64. doi: 10.1007/s00784-012-0820-3. Epub 2012 Aug 16.

引用本文的文献

1
GILT stabilizes cofilin to promote the metastasis of prostate cancer.GILT使丝切蛋白稳定,以促进前列腺癌转移。
Cell Death Discov. 2025 Jan 16;11(1):10. doi: 10.1038/s41420-025-02288-0.
2
Association between severity of diabetic complications and risk of cancer in middle-aged patients with type 2 diabetes.2型糖尿病中年患者糖尿病并发症严重程度与癌症风险之间的关联。
J Diabetes Investig. 2025 Jan;16(1):16-24. doi: 10.1111/jdi.14364. Epub 2024 Nov 22.
3
Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies.

本文引用的文献

1
Diabetes and cancer: a consensus report.糖尿病与癌症:共识报告。
Diabetes Care. 2010 Jul;33(7):1674-85. doi: 10.2337/dc10-0666.
2
History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study.糖尿病史与前列腺癌风险:大崎队列研究。
Cancer Causes Control. 2010 Jul;21(7):1025-32. doi: 10.1007/s10552-010-9530-9. Epub 2010 Mar 13.
3
Diabetes and risk of incident cancer: a large population-based cohort study in Israel.糖尿病与癌症发病风险:以色列一项基于人群的大型队列研究。
二甲双胍对前列腺癌患者发病率、复发率和死亡率的影响:整合来自真实世界研究的证据
Prostate Cancer Prostatic Dis. 2025 Mar;28(1):210-219. doi: 10.1038/s41391-024-00871-7. Epub 2024 Jul 16.
4
The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization.糖尿病与前列腺癌的关联:一项荟萃分析和孟德尔随机化研究。
Aging (Albany NY). 2024 Jun 4;16(11):9584-9598. doi: 10.18632/aging.205886.
5
Metformin: A Dual-Role Player in Cancer Treatment and Prevention.二甲双胍:癌症治疗与防治中的双重角色
Int J Mol Sci. 2024 Apr 6;25(7):4083. doi: 10.3390/ijms25074083.
6
Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.罗格列酮与 2 型糖尿病患者前列腺癌风险之间无关联。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1185053. doi: 10.3389/fendo.2023.1185053. eCollection 2023.
7
Evaluating Metformin Strategies for Cancer Prevention: A Target Trial Emulation Using Electronic Health Records.评估二甲双胍在癌症预防中的策略:基于电子健康记录的目标试验模拟。
Epidemiology. 2023 Sep 1;34(5):690-699. doi: 10.1097/EDE.0000000000001626. Epub 2023 May 23.
8
Cancer of the Liver and its Relationship with Diabetes mellitus.肝癌及其与糖尿病的关系。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221119743. doi: 10.1177/15330338221119743.
9
LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration.前列腺癌中LMO3的下调:一种与免疫浸润相关的潜在生物标志物。
Front Genet. 2022 Sep 19;13:945151. doi: 10.3389/fgene.2022.945151. eCollection 2022.
10
The short inverted repeats-induced circEXOC6B inhibits prostate cancer metastasis by enhancing the binding of RBMS1 and HuR.短反向重复序列诱导的 circEXOC6B 通过增强 RBMS1 和 HuR 的结合抑制前列腺癌转移。
Mol Ther. 2023 Jun 7;31(6):1705-1721. doi: 10.1016/j.ymthe.2022.08.006. Epub 2022 Aug 15.
Cancer Causes Control. 2010 Jun;21(6):879-87. doi: 10.1007/s10552-010-9515-8. Epub 2010 Feb 11.
4
Serum creatinine and prostate cancer risk in a prospective study.血清肌酐与前列腺癌风险的前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2643-9. doi: 10.1158/1055-9965.EPI-09-0322. Epub 2009 Sep 15.
5
The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.糖尿病对前列腺癌的保护作用:性激素的作用。
Prostate. 2009 Dec 1;69(16):1744-50. doi: 10.1002/pros.21023.
6
Diabetes and cancer.糖尿病和癌症。
Endocr Relat Cancer. 2009 Dec;16(4):1103-23. doi: 10.1677/ERC-09-0087. Epub 2009 Jul 20.
7
Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values?糖尿病和体重指数与前列腺特异性抗原水平的关联:对校正前列腺特异性抗原临界值有何影响?
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1350-6. doi: 10.1158/1055-9965.EPI-08-0794. Epub 2009 Apr 21.
8
Association of diabetes with prostate cancer risk in the multiethnic cohort.多民族队列中糖尿病与前列腺癌风险的关联。
Am J Epidemiol. 2009 Apr 15;169(8):937-45. doi: 10.1093/aje/kwp003. Epub 2009 Feb 24.
9
Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.糖尿病患者膀胱癌的年龄相关死亡风险:台湾全国队列的12年随访
Ann Med. 2009;41(5):371-9. doi: 10.1080/07853890902729778.
10
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.健康专业人员随访研究中的糖尿病与前列腺癌风险
Int J Cancer. 2009 Mar 15;124(6):1398-403. doi: 10.1002/ijc.24044.